Performance Evaluation of QMAC-dRAST Using Consecutive Positive Clinical Blood Culture Samples
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Bacteremia is life-threatening to patients, with a case fatality rate of 30–40%. The QMAC-dRAST system (QuantaMatrix, Republic of Korea), which is based on time-lapse imaging technology, can generate antimicrobial susceptibility testing (AST) results earlier than conventional equipment. Here, we evaluated the performance of QMAC-dRAST for positive blood culture samples. Methods: In total, 204 isolates were collected from positive blood cultures, with 104 Gram-positive cocci (GPC) and 100 Gram-negative rods (GNR), including Staphylococcus spp., Enterococcus spp., Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter spp. Before and after improvement of the AST algorithm, 67 GPC isolates and 72 GNR isolates were tested and their results were compared. In the final test, 37 GPC and 28 GNR were added, and the agreement rates between QMAC-dRAST and Vitek 2 were analyzed using 204 samples. To resolve discrepant AST results between two systems, broth microdilution tests were performed. Results: In the first and second tests with 67 GPC and 72 GNR, the categorical agreement (CA) between QMAC-dRAST and Vitek 2 was increased from 92.7% and 96.2% to 94.3% and 96.5% by updating the AST algorithm, respectively. For all 204 samples, the agreement rates were 94.5% and 95.4% for CA; 4.8% and 0.6% for very major errors; 2.5% and 2.0% for major errors; and 2.1% and 3.0% for minor errors. Conclusions: The QMAC-dRAST system has reliable performance and the advantage of faster AST reporting than conventional methods. This system will demonstrate more acceptable agreement rates with conventional AST systems in the future by improving AST algorithms.
Abstract
Background: Bacteremia is life-threatening to patients, with a case fatality rate of 30–40%. The QMAC-dRAST system (QuantaMatrix, Republic of Korea), which is based on time-lapse imaging technology, can generate antimicrobial susceptibility testing (AST) results earlier than conventional equipment. Here, we evaluated the performance of QMAC-dRAST for positive blood culture samples. Methods: In total, 204 isolates were collected from positive blood cultures, with 104 Gram-positive cocci (GPC) and 100 Gram-negative rods (GNR), including Staphylococcus spp., Enterococcus spp., Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter spp. Before and after improvement of the AST algorithm, 67 GPC isolates and 72 GNR isolates were tested and their results were compared. In the final test, 37 GPC and 28 GNR were added, and the agreement rates between QMAC-dRAST and Vitek 2 were analyzed using 204 samples. To resolve discrepant AST results between two systems, broth microdilution tests were performed. Results: In the first and second tests with 67 GPC and 72 GNR, the categorical agreement (CA) between QMAC-dRAST and Vitek 2 was increased from 92.7% and 96.2% to 94.3% and 96.5% by updating the AST algorithm, respectively. For all 204 samples, the agreement rates were 94.5% and 95.4% for CA; 4.8% and 0.6% for very major errors; 2.5% and 2.0% for major errors; and 2.1% and 3.0% for minor errors. Conclusions: The QMAC-dRAST system has reliable performance and the advantage of faster AST reporting than conventional methods. This system will demonstrate more acceptable agreement rates with conventional AST systems in the future by improving AST algorithms.
참고문헌 (25)
- Ibrahim EH, "The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting", Chest, 118, pp.146~155 (2000)
- Leibovici L, "Long-term survival following bacteremia or fungemia", JAMA, 274, pp.807~812 (1995)
- Lee Y, "Recent trends in antimicrobial resistance in intensive care units in Korea", Korean J Nosocomial Infect Control, 19, pp.29~36 (2013)
- Liu C, "Antimicrobial resistance in South Korea : A report from the Korean global antimicrobial resistance surveillance system(Kor-GLASS)for 2017", Infect Chemother, 25, pp.845~859 (2019)
- 서일혜, "한 3차 대학병원의 혈액배양 분석(2006년-2015년)", Annals of Clinical Microbiology, 20(2), pp.35~41 (2017), 대한임상미생물학회
- 박은숙, "중소병원의 의료관련감염 감시", 의료관련감염관리, 16(2), pp.54~62 (2011), 대한의료관련감염관리학회
- 이훈구, "Blood Stream Infections in Patients in the Burn Intensive Care Unit", Infection and Chemotherapy, 45(2), pp.194~201 (2013), 대한감염학회
- van Belkum A, "Innovative and rapid antimicrobial susceptibility testing systems", Nat Rev Microbiol, 18, pp.299~311 (2020)
- Quesada MD, "Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT", ALERT blood culture bottles, 2010, pp.16, 137~140
- Choi J, "Direct, rapid antimicrobial susceptibility test from positive blood cultures based on microscopic imaging analysis", Sci Rep, 7, pp.1148~ (2017)
- Choi J, "Rapid antibiotic susceptibility testing by tracking single cell growth in a microfluidic agarose channel system", Lab Chip, 13, pp.280~287 (2013)
- Wang HY, "Quantamatrix Multiplexed Assay Platform system for direct detection of bacteria and antibiotic resistance determinants in positive blood culture bottles", Clin Microbiol Infect, 23, pp.333~ (2017)
- Kim JH, "Direct rapid antibiotic susceptibility test(dRAST)for blood culture and its potential usefulness in clinical practice", J Med Microbiol, 67, pp.325~331 (2018)
- Grohs P, "Comparative evaluation of the QMAC-dRAST V2. 0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates", J Microbiol Methods, 172, pp.105902~ (2020)
- Huh HJ, "Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture : a comparative study of performance with the VITEK-2 system", J Antimicrob Chemother, 73, pp.1267~1271 (2018)
- 김현정, "Clinical Evaluation of QMAC-dRAST for Direct and Rapid Antimicrobial Susceptibility Test with Gram-Positive Cocci from Positive Blood Culture Bottles", Annals of Clinical Microbiology, 21(1), pp.12~19 (2018), 대한임상미생물학회
- Clinical and Laboratory Standards Institute, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically" (2018), Clinical and Laboratory Standards Institute
- "Antimicrobial Susceptibility Test (AST) Systems - Class II special controls guidance for Industry and FDA" (2018)[URL]
- van Belkum A, "Innovative and rapid antimicrobial susceptibility testing systems", Nat Rev Microbiol, 18, pp.299~311 (2020)
- Jin WY, "Evaluation of VITEK 2, MicroScan, and Phoenix for identification of clinical isolates and reference strains", Diagn Microbiol Infect Dis, 70, pp.442~447 (2011)
- Banerjee R, "Rapid antimicrobial susceptibility testing methods for blood cultures and their clinical impact", Front Med(Lausanne), 8, pp.635831~ (2021)
- Gaynes R, "Overview of nosocomial infections caused by gram-negative bacilli", Clin Infect Dis, 41, pp.848~854 (2005)
- Klevens RM, "Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003", Clin Infect Dis, 42, pp.389~391 (2006)
- Ramsey AM, "Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000–2006", Infect Control Hosp Epidemiol, 30, pp.184~186 (2009)
- 이경원, "지난 50년간 국내 항생제 내성의 변화와 향후 전망 - 그람음성 세균", Infection and Chemotherapy, 43(6), pp.458~467 (2011), 대한감염학회